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Objective: Aiming at elucidating the effects on capillary blood flow and tissue 
oxygenation ofhyperoxemia during cardiopulmonary b pass, we studied skeletal 
musde surface oxygen tensions in 10 patients undergoing elective cardiac opera- 
tions. Methods: In a prospective investigation each patient was exposed to normox- 
emia (arterial oxygen tension 75 to 115 mm Hg) and hyperoxemia ( rterial oxygen 
tension > 185 nun Hg, inspired oxygen fraction = 1.00) during normal anesthe- 
tized conditions before and after cardiopulmonary b pass, as well as during 
normothermic and hypothermic continuous-flow bypass. In each state hemody- 
namic variables and arterial and mixed venous blood gas and acid base values 
were measured. From these data oxygen transport variables were calculated. 
Tissue oxygenation was studied with the use of a multiple-point polarographic 
oxygen microelectrode, known to provide measures of oxygen tensions at the 
capillary level. The oxygen distribution profile of such a sample is also indicative 
of capillary blood flow distribution changes. Resu/ts: In all patients and at each 
occasion of the investigation markedly low mean surface oxygen tensions in 
skeletal muscle were r gistered. When hyperoxemia was instituted, a significant 
decrease in these surface oxygen tensions together with an increase in distribution 
heterogeneity was seen during all stages. Contrary to prebypass, postbypass, and 
hypothermic bypass, where vascular resistance, oxygen delivery, and oxygen 
consumption remained similar during hyperoxemia and normoxemia,  signifi- 
cant (p < 0.05) increase in vascular esistance together with a decline in oxygen 
consumption was seen during hyperoxemic normothermic (35 ° to 36 ° C) cardio- 
pulmonary bypass. Conclusion: These findings show that the microcirculatory 
response to hyperoxemia, seen under other circumstances, persists during contin- 
uous-flow cardiopulmonary b pass, normothermic aswell as hypothermic. If these 
adverse ffects on tissue oxygenation by hyperoxemia can be further verified and 
shown to be valid for other organs than skeletal muscle, we would suggest that 
hyperoxemia should be avoided, especially during normothermic cardiopulmonary 
bypass. (J Thorac Cardiovasc Surg 1996;112:812-9) 
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p eripheral tissue perfusion is disturbed and re- 
duced during hypothermic ardiopulmonary by- 
pass (CPB) with both a reduced flow and a contin- 
uous flow pattern.*' 2This disturbance has also been 
demonstrated by a lower average oxygen tension in 
skeletal muscle. 3 Under  such circumstances it may 
be tempting to assume that a supernormal arterial 
oxygen tension (Pa02) would provide improved oxy- 
gen delivery to peripheral tissue and an increased 
margin of safety, and often the Pao 2 is kept above 
normal values. On the contrary, however, exces- 
sively high Pao 2 values may be harmful. Adverse 
influence of hyperoxemia on red blood ceils, peri- 
operative complications, and morbidity during CPB 
has been reported. 4 Hyperoxemia lso disturbs and 
reduces tissue oxygenation i  healthy subjects under 
normal resting conditions, as well as in mechanically 
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ventilated critically ill patients. This is seen as an 
increase in the range of tissue oxygen tensions of 
different adjacent capillary regions, where some 
extremely low values are observed, s'6 The change in 
oxygen tension distributions een during hyperox- 
emia has been found to be due to changes in 
capillary flow, possibly mediated by serotonin. 7 It is 
not known if this response to hyperoxemia is re- 
tained during hypothermic CPB. If this is the case, 
tissue perfusion would be further impaired and 
possibly inadequate. 
Multiple-point microelectrodes for measurement 
of muscle surface oxygen tensions (Pm02) are avail- 
able and can be sterilized and mounted aseptically 
for use in the operating field. 6' 8 In this study such an 
electrode was used to monitor peroneal Pm02 values 
during cardiac operations. 
The aim of the study was to observe the influence 
of arterial normoxemia nd hyperoxemia, respec- 
tively, on peripheral muscle oxygenation before, 
during, and after hypothermic continuous-flow CPB. 
Patients and methods 
Patients. Ten adult patients, nine men and one woman, 
undergoing CPB for elective cardiac operations were 
studied during the operation. The patients were selected 
after giving their informed consent. The study was ap- 
proved by the Ethics Committee of the University Hospi- 
tal of Link6ping. The surgical procedures were aortic 
valve replacement in one case, closure with direct suture 
of an atrial septal defect and coronary artery bypass 
grafting (CABG) in one case, and CABG in the other 
eight cases. Patients undergoing CABG all had three- 
vessel disease. All patients had good or only moderately 
impaired left ventricular function. 
Anesthesia. The patients were premedicated with 1 mg 
of flunitrazepam on the evening before the operation and 
oxycodone and scopolamine, 7.5 to 10 mg and 0.3 to 0.4 
rag, respectively, 1 to 2 hours before induction of anes- 
thesia. Patients receiving/3-blocking medication (seven of 
eight patients undergoing CABG) were given their ordi- 
nary morning dose at the time of premedication. Anes- 
thesia was induced with fentanyl, thiopental, and pancu- 
ronium and was maintained with isoflurane (0.5% to 
0.75%) and intermittent doses of fentanyl. The total dose 
(mean +- standard eviation) during the operation was 1.4 
+- 05 mg/kg for thiopental, 25 _+ 7/~g/kg for fentanyl, and 
0.10 _+ 0.01 mg/kg for pancuronium. After intubation, the 
patients' lungs were mechanically ventilated with an oxy- 
gen-in-air mixture, with the inspired oxygen fraction being 
varied to achieve the desired Pao2. Ventilation was ad- 
justed to provide arterial carbon dioxide tensions within 
the normal range of 30 to 40 mm Hg, as well as normal 
arterial pH values. 
CPB. In all patients the distal portion of the ascending 
aorta was used as the site for aortic cannulation. Femoral 
vessels were not manipulated in any way in any patient. 
During CPB a standard roller pump heart-lung machine 
and heating/cooling device (St6ckert CAPS and St6ckert 
Heater-Cooler, St6ckert Instrumente, Munich, Germany) 
were used. The membrane oxygenator (Sorin Monolyth, 
Sorin Biomedica SPA, Saluggia, Italy) and the tubing were 
primed with 1.5 to 1.7 L of Ringer's acetate solution and 
100 ml mannitol 150 mg/ml. During CPB hemoglobin 
values of 75 to 90 gm/L were intended. The CPB was 
conducted in a continuous-flow mode. At normothermia 
the pump flow was 2.2 L/rain per square meter. During 
aortic occlusion moderate hypothermia of 28 ° C, guided 
by nasopharyngeal temperature, was induced. After that 
temperature was reached, a flow of 1.8 to 2.0 L/rain per 
square meter was used until rewarming. The gas fow from 
the oxygenator was adjusted to maintain alpha-stat regu- 
lation of acid-base status during hypothermia. Acid-base 
status, blood gases, and oxygen saturations were checked 
with intermittent samples analyzed by automated analyz- 
ers (ABL 4 and OSM 3, Radiometer A/S, Copenhagen, 
Denmark). Arterial oxygenation before, during, and after 
CPB was altered according to the study protocol. An 
on-line continuous blood gas monitor (CDI System 400, 
3M Health Care, Tustin, Calif.) with the sensor incorpo- 
rated in the circuitry was used to facilitate and improve 
adjustments needed to achieve the intended Pao 2 levels 
during CPB. 
Monitoring. Two peripheral venous lines and one arte- 
rial cannula in the left radial artery were inserted before 
induction of anesthesia. After intubation a triple-lumen 
central venous catheter and a balloon-tipped flow-di- 
rected thermodilution fiberoptic pulmonary artery cathe- 
ter (PTl10 Opticath catheter connected to an Oximetrix 3 
instrument, Abbott Critical Care systems, Mountain View, 
Calif.) were inserted percutaneously via the right internal 
jugular vein. Rectal and nasopharyngeal standard temper- 
ature probes were placed. Arterial, pulmonary artery, and 
central venous pressures were measured with standard 
transducers. The pressure values, temperatures, intermit- 
tent cardiac output measurements, and derived variables 
were monitored and recorded on the monitoring equip- 
ment in the operating room (Hewlett-Packard Merlin 
System, Hewlett-Packard, North Hollywood, Calif.). 
Study protocol. Measurements, including blood gas 
analyses, hemodynamic variables, and Pmo 2 values, were 
recorded during normoxemia nd hyperoxemia on four 
occasions. On each occasion astabilization period of 10 to 
15 minutes was allowed after switching from normal to 
high or high to normal Pao 2. The first set of measure- 
ments, M1, was performed uring stable anesthesia after 
sternotomy and after an initial stabilization period after 
preparation and mounting of the Pmo 2 electrode. Then 
measurements were first obtained during normoxemia 
(Pao 2 in the range of 75 to 115 mm Hg), M1N. After that 
the inspired oxygen fraction was increased to produce 
hyperoxemia (Pao 2 > 185 mm Hg). After the equilibra- 
tion interval the next measurements of this phase, M1H, 
were performed. Hyperoxemia was then maintained until 
stable hypothermic CPB (28 ° C nasopharyngeal tempera- 
ture) had been established, when the next set of measure- 
ments were done, M2H. Then the oxygen supply to the 
oxygenator was decreased to achieve normoxemia nd, 
after a stabilization period, measurements M2N were 
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Fig. 1. Pmo 2 for one patient (No. 6) during normoxemic and hyperoxemic onditions before CPB 
(Normoxia 1, MIN, and Hyperoxia 1, MIH), and after CPB (Hyperoxia 4, M4H, and Normoxia, M4N). 
Values are presented as cumulated relative frequencies on the y-axis, with the 0.50 value corresponding to 
the median. Each of the four histograms is constructed from 120 separate Pmo 2 values. 
Tab le  I. Pao 2, temperature, and hemodynamic data at measurement occasions 
Pre-CPB Cold CPB Warm CPB Post-CPB 
M1N M1H M2H M2N M3N M3H M4H M4N 
Pao  2 (mm Hg) 108 _+ 19 356 ± 148 284 _+ 65 93 + 16 83 ± 12 281 + 48 344 4- 128 96 ± 23 
TNP (°C) 35.2 -+ 0.2 35.0 _+ 0.2 27.3 _+ 0.3 27.7 + 0.3 38.l -+ 0.4 36.6 4- 0.2 35.7 _+ 0.5 35.8 _+ 0.5 
Hb (gm/dl) 12.6 ± 0.5 12.4 _+ 0.5 8.9 _+ 0.4 9.1 ± 0.4 9.2 ± 0.4 9.3 +_ 0.4 9.7 _+ 0.4 10.0 _+ 0.5 
CI (L/min/m 2) 1.8 _+ 0.1 2.2 + 0.1 2.0 + 0.1 2.0 ± 0.4 2.4 + 0.1 2.4 _+ 0.1 2.1 _+ 0.1 2.1 _+ 0.1 
Svo2 (%) 72.7 -+ 7.8 78.9 _+ 7.9 85.8 _+ 7.7* 80.9 -+ 3.1 67.6 -+ 8.4 79.1 _+ 2.6 72.2 _+ 8.3? 64.2 -- 5.3 
All values are presented as mean -+ standard deviation. M1N... M4N, Measurement during normoxemia before CPB, during cold and normothermic CPB, 
and after CPB, respectively; MIH... M4H, measurement during hyperoxemia at respective stage of surgery; Pao2, arterial oxygen tension; TNe, 
nasopharyngeal temperature; Hb, hemoglobin concentration; Cl, cardiac index; Svo2, oxygen saturation in mixed venous blood. Pao2, TNP, Hb, and CI are 
manipulated instrumental variables and, h nce, are presented without statistical analysis results. 
*p < 0.01, normoxemia versus hyperoxemia. 
?p < 0.05, normoxemia versus hyperoxemia. 
undertaken. After unclamping of the aorta nd rewarming 
to approximately 35 ° C rectal temperature, the third set of 
measurements were performed, M3N at normoxemia nd 
then M3H after hyperoxemia was established. The last set 
of measurements were carried out during stable sponta- 
neous circulation after terminating CPB and after giving 
protamine, M4H during hyperoxemia nd finally M4N 
after an equil ibration interval with normoxemia. 
Hemodynamie  measurements .  At each measurement  
occasion mean arterial (MAP) and central venous pres- 
sures (CVP), cardiac output (CO), temperatures, and 
blood gas analyses were obtained. Hemodynamical ly de- 
rived variables were calculated according to standard 
formulas. 
Systemic vascular resistance (SVR) was calculated as 
follows: 
MAP - CVP 
SVR - × 80 dyne × sec × cm -s  
CO 
where pressures were measured in mill imeters of mercury 
and cardiac output in liters per minute. 
Cardiac output was normalized to cardiac index (CI, 
L/min × m 2) by dMding with body surface area. 
Oxygen contents (C02) of arterial and mixed venous 
blood were calculated as follows: 
Co 2 = Hb × 1.37 × So  2 q- 0.0034 × Po 2 (ml/L) 
where hemoglobin (Hb) is given in grams per deciliter, 
1.37 is the volume of oxygen (ml) carried by 1 gm of fully 
saturated hemoglobin, S% is fractional oxygen saturation 
of hemoglobin, 0.0034 is the solubility coefficient of 
oxygen in plasma, and Po z is the oxygen tension (ram Hg) 
in plasma. 
The formula for oxygen delivery (Do2I) is as follows: 
D02I = Co 2 X CI (ml/min × m 2) 
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Fig. 2. Pmo2 during CPB for one patient (No. 6) under normoxemic and hyperoxemic conditions 
(Normoxia 2 and 3, M2N and M3N, and Hyperoxia 2 and 3, M2H and M3H). Values are presented as 
cumulated relative frequencies on the y-axis, with the 0.50 value corresponding to the median. Each of the 
four histograms i constructed from 120 separate Pmo 2 values. 
Oxygen consumption i dex('Qo2I ) was determined by this 
equation: 
~'o2I = A-vDo 2 X CI (ml/min × m 2) 
where A-vDo 2 is arteriovenous oxygen content difference. 
Pmo 2 measurements. An eight-channel oxygen micro- 
electrode (L. Eschwefler and Co., Kiel, Germany) was 
used for measurements of skeletal muscle Pmo2Z The 
electrode consists of eight platinum wires. Each wire has a 
diameter of 15 ixm and is embedded in a glass cylinder. 
The electrode is covered with a cellophane inner mem- 
brane (12 tzm) containing potassium chloride in a concen- 
tration of 0.20 mol/L and with an outer Teflon membrane 
(12 Ixm). Sterilization and calibration of the electrode 
system was done according to the method of Lund and 
associates s and Odman and Lund. 1° At each measure- 
ment occasion the electrode was rotated 15 times at 
intervals of 10 seconds, giving a total of 120 Pmo 2 values. 
Thus sampling during a 3-minute period at each measure- 
ment generates a distribution of Pmo 2 values that can be 
used to create a histogram characterizing the state of 
tissue oxygenation atthat occasion. The Pmo 2 values were 
processed by an eight-bits resolution analog-to-digital 
converter and recorded and stored by a personal com- 
puter for subsequent calculations and data analyses. Mus- 
cle temperature was recorded. Pmo 2 values were cor- 
rected to actual muscle surface temperatures. The 
temperature ffect on the electrode is 1.3%/°C. The 
electrode has a linear oxygen dependence in the temper- 
ature range of 20° to 40 ° C, which is taken into account in 
the calculation program. 
After induction of anesthesia small incision for 
mounting of the electrode on the surface of a muscle was 
made on the left leg, or the leg that was not used for 
harvesting of vein grafts in the case of CABG operations. 
The fascia over the anterior tibial muscle was incised and 
removed in a small area, allowing the application of a 
Lucite methyl methacrylate ring. This ring served as an 
electrode holder, which was carefully placed on the ex- 
posed muscle surface. The body of the electrode and its 
cable were dressed in a sterile plastic sleeve, and the 
sterile electrode tip was mounted into the holder. Before 
the end of the study, samples for bacterial cultures were 
obtained from the application site. 
Statistical analyses. Pmo 2 values from normoxemic 
and hyperoxemic conditions during each of the four stages 
of the operation were compared by means of two-way 
analysis of variance with Fisher's least significant differ- 
ence comparison report using all valid Pro02 data for all 
patients at the respective occasion. For paired compari- 
sons of hemodynamic and oxygen transport variables 
during hyperoxemic and normoxemic conditions, the Wil- 
coxon signed rank test was used with Bonferroni-adjusted 
significance levels. Results are presented as mean _+ 
standard eviation. Values ofp < 0.05 were considered to 
be statistically significant. 
Results 
Factors known to influence tissue perfusion, such 
as vasodi lators, inotropic agents, or vasoconstrictors, 
were not used during CPB at all, but vasodi lators 
were used in four patients before CPB and in two of 
those patients also after CPB. CPB durat ion was 99 
+ 14 minutes (mean _+ standard deviat ion) and 
aort ic crossclamp t ime was 42 _+ 16 minutes. 
Temperatures  of the nasopharynx, hemoglobin 
concentrat ions in blood, cardiac index, mixed ve- 
nous oxygen saturations, and arterial  oxygen ten- 
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Fig. 4. Systemic oxygen delivery index during normox- 
emic versus hyperoxemic conditions during four different 
stages of surgery. Means _+ standard eviations are given. 
Paired comparisons were analyzed by means of the Wil- 
coxon signed rank test with Bonferroni-adjusted signifi- 
cance levels. *p < 0.05. 
sions (Pa02) are given in Table I for each measure- 
ment occasion. Nasopharyngeal temperature and 
hemoglobin concentrations showed no differences 
between normoxemic and hyperoxemic conditions 
at any of the four studied stages of the operation. 
Cardiac index was increased uring rewarming but 
was otherwise similar at all stages. Pao 2 values could 
be held within the intended ranges during measure- 
ments, were significantly different during normox- 
emic and hyperoxemic conditions (p < 0.001), and 
did not overlap. Venous oxygen saturations were 
higher during hyperoxemia, reaching statistical sig- 
nificance during hypothermic CPB and after CPB. 
Tissue oxygenation. A common pattern during 
change from normoxemia to hyperoxemia was seen 
as an increase in distribution heterogeneity of Pm02 
values as well as an increasing number of low values. 
Distributions of Pm02 values at the eight measure- 
ments from one randomly chosen patient are shown 
in Figs. 1 and 2. Also, mean Pm02 values for the 
different measurement occasions were consistently 
and significantly lower during hyperoxemia than 
during normoxemia before and after CPB, as well as 
during hypothermic and normothermic CPB (Fig. 
3). 
Central hemodynamics and oxygenation. Global 
systemic oxygen delivery was slightly higher during 
hyperoxemia during both cold and warm CPB (Fig. 
4). During normothermic CPB, measurements M3N 
and M3H, global systemic oxygen uptake was lower 
(Fig. 5), and systemic vascular esistance and mean 
arterial pressure (p < 0.05) were higher during 
hyperoxemia (Fig. 6). The values of mean arterial 
pressure followed the same pattern as that of sys- 
temic vascular esistance. 
Clinical course. No positive bacterial cultures 
from the electrode application sites or clinical com- 
plications from that site were seen. Similarly no 
other clinical complications were noted. 
Discussion 
In this study hyperoxemia increased global oxygen 
delivery and oxygen saturation in mixed venous 
blood during CPB. This effect might be assumed to 
provide improved tissue oxygenation and safety. 
However, muscle oxygenation deteriorated uring 
hyperoxemia. This paradoxic finding and other re- 
ported untoward effects of hyperoxemia during 
CPB 4 call for further investigations about he effects 
and safety of hyperoxemia and suggest hat hyper- 
oxemia perhaps hould be avoided. 
In several investigations in which tissue oxygen- 
ation was studied, decreased oxygenation, some- 
times even to hypoxic levels, together with signs of a 
maldistributed capillary flow has been found as a 
response to hyperoxemia. 5-7It is not known whether 
these capillary blood flow regulating mechanisms 
are maintained uring hypotensive, hypothermic, or 
nonpulsatile flow conditions, such as CPB. In pa- 
tients undergoing CABG operations, atherosclerosis 
present elsewhere in the vascular system may also 
interfere with these flow-regulating mechanisms. If 
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the normal capillary flow response to hyperoxemia, 
that is, flow reduction, is not maintained, then 
hyperoxemia would probably provide improved tis- 
sue oxygenation. However, the results of this study 
show that the capillary flow-regulating mechanisms 
induced by hyperoxemia, described earlier in 
healthy volunteers 5 and critically ill patients, 6 re- 
main present, irrespective of the decline in perfu- 
sion pressure, temperature, the presence of a non- 
pulsatile flow pattern, and probably concomitant 
atherosclerosis. 
The organ surface microelectrode method used in 
this study 11 measures close to the oxygen target, that 
is, at the capillary level near the cell. The multiple- 
point setup supplies data of organ surface oxygen 
distributions, which are important because single 
oxygen measurements vary along and radially to the 
capillary. 12 The local Pmo 2 values depend on the 
interaction between oxygen delivery and consump- 
tion. However, the Pmo 2 values and especially the 
distributions of sampled Pm02 values are affected to 
a larger degree by capillary flow alterations rather 
than changes in local oxygen consumption. 7 Low 
Pm02 values, as measured by this technique, are of 
physiologic importance because they may indicate 
hypoxic areas with concomitant local tissue acido- 
sis. 13 The shortcomings of the method are that 
organ surface measurements may not necessarily 
reflect deeper portions of the tissues. However, for 
skeletal muscle no anatomic differences exist be- 
tween different locations within the muscle; thus it 
has been claimed that the results are indicative of 
the organ as a whole. 14 One has to be cautious in 
extrapolating the results to other organs, however, 
especially those with structured capillary beds. 
Oxygen has long been claimed to be one of the 
important factors regulating blood flow through its 
effect on the metabolism of parenchymal cells, 
which secondarily produce metabolites known to 
alter blood flowJ 5 The oxygen effects could also be 
mediated by the vessels themselves 16 and by the 
endothelium.17, is Most studies in this respect have 
investigated the effect of hypoxia/hypoxemia 17' 18 
and few have thoroughly addressed the effects on 
capillary blood flow seen during hyperoxemia. How- 
ever, previous studies, contrary to what was ex- 
pected, have found decreasing tissue oxygen levels 
both in skeletal muscle 5'6' 19 and in the brain 2° 
during exposure to hyperoxemia. Thorborg and co- 
workers, 7 measuring capillary blood flow in skeletal 
muscle during hyperoxemia, found a decrease in 
capillary blood flow as the reason for the decreased 
tissue oxygen levels. It has been claimed that this 
flow change is mediated by increased capillary levels 
of serotonin, due either to a decrease in serotonin 
metabolism by the lung or endothelial cells 21 or to a 
suggested increase in the release of serotonin by 
platelets. 7 It has also been claimed that hyperoxemia 
inactivates the endothelium-derived r laxing factor 
(nitric oxide) and thereby causes vasoconstriction at 
the capillary level. 22 Possibly, serotonin and the 
release of nitric oxide in hyperoxemia re also 
linked. 23 
Several of the factors that have been considered 
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to be important for the hyperoxemically induced 
changes in capillary blood flow (e.g. inflammatory 
mediators, platelet function, platelet activation, se- 
rotonin release, and blood flow profile) may be 
affected by CPB. Platelets, granulocytes, coagula- 
tion, and inflammatory mediators are activated by 
the CPB circuit to produce a "whole body inflam- 
matory response. ''24' 25 If vasoconstriction was the 
net effect, then this response might help to explain 
the low Pmo2 values seen during CPB in this and a 
previous tudy. 3 Pulsations are also known to stim- 
ulate vasodilation mediated by the endothelium, 26 
and the nonpulsatile flow during CPB might be 
attributable to the impaired capillary flow and oxy- 
genation seen here and previously. 3 However, Pmo 2 
values were low also before and after CPB. These 
low values might be attributable to the stable but 
low arterial blood pressures during anesthesia and 
are in agreement with the mechanism of flow and 
shear stress inducing vasodilation. 27
Central hemodynamics were not influenced by the 
changes from normoxemia to hyperoxemia except 
for significantly higher systemic vascular esistance 
and mean arterial pressure and lower global oxygen 
uptake during hyperoxemic normothermic CPB, 
that is, late during the bypass period. Systemic 
effects of regional microvascular changes induced by 
hyperoxemia were not really expected. However, if 
the lowering of Pmo2 and increased heterogeneity in 
the capillary perfusion seen during hyperoxemia 
were widespread in skeletal muscle or perhaps be- 
yond that organ, the disturbance of capillary ex- 
change of oxygen might be large enough to be 
detected systemically. This reasoning may also be 
valid for the observed effect on arterial pressure and 
vascular resistance. We believe that the hyperox- 
emic response works by constricting precapillary 
arterioles. A small but consistent increase of sys- 
temic vascular resistance index as a response to 
hyperoxemic periods both during and after CPB, 
although not statistically significant, has been re- 
ported previously. 28 Systemic hanges were not seen 
during the other stages of the operation; however, it 
may be argued that late during bypass the nonpul- 
satile flow and other profound changes discussed 
earlier, which are brought about by CPB, might 
potentiate the hyperoxemic response of the micro- 
vasculature to significantly alter systemic parameters 
as well. Even though skeletal muscle capillary ex- 
change of oxygen seems to be disturbed by hyper- 
oxemia, there were no signs of concomitantly re- 
duced mixed venous oxygen saturation at any 
occasion. This is, however, not to be expected 
because profound regional venous desaturation and 
even progressive regional acidemia may go undetec- 
ted, while mixed venous saturation is normal. 29 
Thus our findings show that the mechanisms that 
regulate capillary flow and tissue oxygenation ap- 
pear intact and that the untoward effects of hyper- 
oxemia seen during other conditions also occur 
during normothermic and hypothermic CPB. The 
decrease in oxygen consumption after the rewarm- 
ing period, during which increased values were to be 
expected, indicates an unfavorable capillary ex- 
change of oxygen. A substantial body of evidence 
indicates that under both normal and disease states 
hyperoxemia disturbs capillary flow and can impair 
tissue oxygenation. Whether this is true also during 
CPB conditions, as seems to be the case in this 
study, has to be investigated further with respect o 
different organs and to its importance in relation to, 
for example, morbidity. If the untoward effects of 
hyperoxemia during CPB can be established further, 
this will call for continuous on-line monitoring of 
Pao2, not only as a safeguard to avoid hypoxia but 
also as a means of improving the quality in perform- 
ing CPB and maintaining oxygen tensions within an 
optimal range. 
We express °our g atitude for valuable technical assis- 
tance to Lars-Ake Malmquist, laboratory engineer, and to 
Urban Gustafsson, research assistant. 
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